ABSTRACT Peptide tags fused to proteins are used in a variety of applications, including as affinity tags for purification, epitope tags for immunodetection, or fluorescent protein tags for visualization. However, the peptide tags can disrupt the target protein function. When function is disrupted by fusing a peptide to either the N or C terminus of the protein of interest, identifying alternative ways to create functional tagged fusion proteins can be difficult. Here, we describe a method to introduce protein tags internal to the coding sequence of a target protein. The method employs in vitro Tn7-transposon mutagenesis of plasmids for random introduction of the tag, followed by subsequent Gateway cloning steps to isolate alleles with mutations in the coding sequence of the target gene. The Tn7-epitope cassette is designed such that essentially all of the transposon is removed through restriction enzyme digestion, leaving only the protein tag at diverse sites internal to the ORF. We describe the use of this system to generate a panel of internally epitope-tagged versions of the Saccharomyces cerevisiae GPI-linked membrane protein Dcw1 and the Candida glabrata transcriptional regulator Sir3. This internal protein tagging system is, in principle, adaptable to tag proteins in any organism for which Gateway-adapted expression vectors exist. KEYWORDS Saccharomyces; epitope tag; protein tagging; transposition R ECOMBINANT fusion proteins are essential tools in molecular studies across all organisms. Fusing fluorescent proteins to a protein of interest (POI) allows for direct visualization in situ. Fusing peptide epitopes, for which antibodies have been developed, to the POI is fundamental to many techniques, including Western blots, immunofluorescence, co-immunoprecipitation, chromatin immunoprecipitation, and purification (Arnau et al. 2006; Young et al. 2012; Bell et al. 2013) .
R
ECOMBINANT fusion proteins are essential tools in molecular studies across all organisms. Fusing fluorescent proteins to a protein of interest (POI) allows for direct visualization in situ. Fusing peptide epitopes, for which antibodies have been developed, to the POI is fundamental to many techniques, including Western blots, immunofluorescence, co-immunoprecipitation, chromatin immunoprecipitation, and purification (Arnau et al. 2006; Young et al. 2012; Bell et al. 2013) .
We describe an approach to add a protein or peptide epitope to a POI. One challenge to epitope tagging is choosing the location to attach the epitope to the POI. The standard design appends the epitope to the N-or C-terminus of the POI. However, in some instances, proteins cannot be tagged at the N or C terminus because a tag interferes with function, disrupting, for example, trafficking or post-translational modification. Tags can also interfere with protein folding or structure and disrupt protein-protein interactions.
Our efforts to study the localization and function of Dcw1 in Saccharomyces cerevisiae have been hampered because we cannot introduce a tag at either terminus. Dcw1 and its paralog Dfg5 are important in cell-wall structure and integrity in S. cerevisiae and other fungi (Kitagaki et al. 2002 (Kitagaki et al. , 2004 Gonzalez et al. 2010; Maddi et al. 2012) . Traditional methods of N-or C-terminally tagging Dcw1 are expected to fail due to interference with protein localization because Dcw1 localization at the cell membrane requires an N-terminal secretory signal sequence and a C-terminal signal sequence for addition of a glycosylphosphatidylinositol (GPI) anchor. Modeled after published constructs (Kitagaki et al. 2002) , we initially engineered an HA-tag located at residue 26 in DCW1 (Dcw1-HA 26 ), just downstream of the N-terminal signal sequence, but found that this tagged protein, while viable, is only partially functional, conferring a temperature-sensitive phenotype. This motivated the development of a transposon-based system to introduce epitope tags throughout DCW1; the resulting library of epitope (33 FLAG)-tagged alleles of DCW1 was then screened for function, permitting the isolation of functional internally tagged alleles of DCW1. To demonstrate the generality of the method, we mutagenized a second gene, SIR3 from Candida glabrata. SIR3 is not an essential gene but is absolutely required for subtelomeric transcriptional silencing in C. glabrata (De Las Penas et al. 2003) . We used the transposon-based method to internally tag CgSIR3 with four different protein tags, including the fluorescent proteins GFP and mEOS2.
Transposons have been used as tools to introduce epitope tags and fluorescent proteins randomly into targets (Merkulov and Boeke 1998; Ross-Macdonald et al. 1999; Manoil and Traxler 2000; Kumar et al. 2002; Sheridan et al. 2002; Kumar et al. 2004; Osawa and Erickson 2005) . In some cases, the transposons are used to identify regions of the target POI into which a tag may be inserted without disrupting target function, requiring later cloning steps to insert the epitope tag at permissive sites (Spreghini et al. 2003) . In a recently described system, TAGIT, Tn5 transposition is used to introduce cassettes containing epitope tags internally into target genes (Gregory et al. 2010) . Resulting insertions are screened to identify in-frame fusions in the target gene. Excision of the bulk of the transposon is done in vivo, using Cre recombinase.
We describe a method, related to TAGIT, using transposon Tn7 and in vitro mutagenesis to introduce epitopes into two different open reading frames (ORFs), generating functional internally tagged alleles. Tn7 mini transposons have been shown to have very little sequence bias, making them ideal tools for random mutagenesis (Biery et al. 2000; Seringhaus et al. 2006; Green et al. 2012) . Our plasmid-based epitopetagging system generates large libraries of internally tagged ORFs, which can be screened for function to identify useful fusion proteins.
Materials and Methods
Plasmids used in this study are listed in Supporting Information, Table S1 . DNA primers are listed in Table S2 .
Media
Escherichia coli was routinely grown at 37°in LB media containing appropriate antibiotics for selection. For any media including trimethoprim, Oxoid Isosensitest media was used instead of LB. Carbenicillin, not ampicillin, was used to select for plasmids marked with the ampicillin-resistance gene. Antibiotics were added at the following final concentrations: carbenicillin (Car; 100 mg/ml), kanamycin (Kan; 30 mg/ml), and trimethoprim (Tmp; 10 mg/ml). Solid media for E. coli growth was supplemented with 1.5% agar.
S. cerevisiae and C. glabrata strains were typically grown at 30°on YPD media (10 g/liter yeast extract, 20 g/liter peptone, 2% dextrose). All solid yeast media contained 2% agar. To maintain His-and Ura-marked plasmids, SD-His (1.7 g/liter yeast nitrogen base without amino acids or ammonium sulfate, 5 g/liter ammonium sulfate, 1.92 g/liter SC-His amino acid mixture, 2% dextrose) or SD-Ura media (1.7 g/liter yeast nitrogen base without amino acids or ammonium sulfate, 5 g/liter ammonium sulfate, 6 g/liter casamino acids, 2% dextrose) were used. To maintain plasmids with a nourseothricin (NAT) marker, YPD was supplemented with 50 mg/ml NAT in liquid media or 100 mg/ml in solid media. To select against Ura-marked plasmids, 5-FOA media (1.7 g/liter yeast nitrogen base without amino acids or ammonium sulfate, 5 g/liter ammonium sulfate, 6 g/liter casamino acids, 25 mg/liter uracil, 1 g/liter 5-FOA, 2% dextrose) was used.
Strains and transformation
All S. cerevisiae strains used in this study are listed in Table S3 ; all C. glabrata strains are listed in Table S4 . Standard lithium acetate transformation protocols were used (Hill et al. 1991) . DH10 E. coli cells were used for routine cloning. Strain BW23473 was used to maintain the Tn7 donor plasmids, which have a R6Kg origin (Metcalf et al. 1996) . DB3.1 (Life Technologies) was used to propagate Gateway destination vectors containing the ccdB cassette. Highly competent MegaX DH10B T1R cells (Life Technologies) were used to maintain large libraries of isolates throughout the mutagenesis procedure.
BY240 strain construction
DCW1 was deleted in a clean two-step loopout from the dfg5DG strain from the yeast knockout collection . Because DCW1 and DFG5 are synthetically lethal (Kitagaki et al. 2002) , the dfg5DG yeast strain was transformed with a His-marked plasmid carrying a wild-type copy of DCW1, prior to deletion of DCW1. The intergenic regions immediately flanking DCW1 were amplified from genomic DNA using primers [1975] [1976] [1977] [1978] . The resulting fragments were cloned into YIPlac211 (URA3-marked). YIPlac211-DCW1 was linearized with a KpnI digest (separating the 59 and 39 flanking regions) and integrated at the DCW1 genomic locus. YIPlac211-DCW1 was replaced with a clean deletion construct, created by amplifying the flanking regions from YIPlac211 with primers 1975 and 1978 . Clean deletions were identified by counterselection against the URA3 marker in YIPlac211-DCW1. This completely removes the DCW1 ORF from the genomic locus and leaves a KpnI scar in its place. A plasmid shuffle replaces the DCW1(His) plasmid with pCU-DCW1, creating BY240.
Tn7-FLAG donor plasmid construction
The transposon FLAG donor plasmid is pRZ101, which carries Tn7-FLAG and is based on the suicide plasmid backbone pJP5603 (Penfold and Pemberton 1992) , which contains the R6Kg origin of replication (ORI). We modified pJP5603 by removing the XbaI site from the polylinker by treatment with Klenow and religation. Overall, the transposon was assembled modularly in other vector backbones and then subcloned into the modified pJP5603 backbone. Tn7L was amplified as a 236-bp fragment from pIC6 using primers 3201 and 3202. This PCR product introduces an FseI site at the distal end of Tn7L and was cloned as a BamHI-AscI fragment. The FLAG epitope is a 33 FLAG tag flanked by flexible linkers. It was synthesized by DNA2.0 and is flanked by AscI and XbaI restriction sites, allowing the FLAG tag to be easily subcloned into the Tn7 donor backbone. The dhfr gene was amplified from pAT-2 (Devine and Boeke 1994) cloned as an XbaI-PstI fragment. The Tn7R end is derived from Tn7R 1-70* in pMCB64 (Biery et al. 2000) (which includes a PmeI site at the distal Tn7R end) and was synthesized as a PstI-EcoRI fragment (DNA2.0).
Other versions of the Tn7-tag donor vector were also constructed.The HA, biotinylation target sequence (bio), 63 His, and 33 myc epitope tags were all synthesized by DNA2.0. The mEOS2 epitope tag was PCR-amplified from pET28-ftsZ-mEOS (a gift of Jie Xiao) using primers 4724 and 4725. The GFP tag was PCR-amplified from pGRB2.3 (Zordan et al. 2013 ) using oligos 5300 and 5301 and then subcloned into the DNA2.0 backbone to position the GFP tag between AscI and XbaI sites in the backbone. All tags were subcloned into the Tn7-tag donor backbone (as described for pRZ101) with the AscI and XbaI sites flanking the epitope tag.
The following sequences for the Tn7-tag donor vectors are available from GenBank: pRZ49 = Tn7-mEOS2 (accession no. KP698385), pRZ98 = Tn7-biotin (accession no. KP698386), pRZ99 = Tn7-6His (accession no. KP698387), pRZ101 = Tn7-FLAG (accession no. KJ939358), pRA102 = Tn7-HA (accession no. KP698388), pRZ103 = Tn7-myc (accession no. KP698389), and pRZ106 = Tn7-GFP (accession no. KP698390).
DCW1 plasmid construction
pCU-DCW1: This plasmid is used in BY240 to cover the synthetic lethality between DCW1 and DFG5 gene deletions. It is derived from p416GPD (Mumberg et al. 1995) , containing the TDH3 (GPD) promoter, CYC1 transcription terminator, and CEN/ARS and URA3 markers for maintenance and selection in S. cerevisiae. The DCW1 ORF was PCR-amplified from S. cerevisiae genomic DNA using primers 1629 and 1630 and subcloned into p416GPD using BamHI and EcoRI.
DCW1-DONR vector (target):
The DCW1 gene was amplified from genomic DNA using oligos that appended standard attB1 (59-GGGGACAAGTTTGTACAAAAAAGCAGGCTA-39) and attB2 (59-GGGGACCACTTTGTACAAGAAAGCTGGGTA-39) sites onto the forward and reverse oligos, respectively. The product was recombined into a Gateway entry vector pDONR201 using a standard Gateway BP clonase II reaction. The sequence of the plasmid was confirmed.
DCW1-destination vector:
The entire intergenic region upstream of the DCW1 ORF was PCR-amplified using primers 6333 and 6334 and cloned into a ccdB-containing backbone using SacI and XbaI restriction sites present in the primers. A SacI-XhoI digest was used to subclone the promoter and ccdB region into the p413GPD backbone (Mumberg et al. 1995) , which contains the CYC1 transcriptional terminator and a HIS1 auxotrophic marker for selection in yeast.
Wild-type DCW1 expression vector: Gateway LR clonase II (Invitrogen protocols) was used to recombine the DCW1-DONR vector and DCW1-destination vector, creating a wild-type, untagged version of the DCW1 expression vector pRZ160.
Dcw1-HA 26 vector: This vector is a derivative of pRZ160 with an HA tag inserted at amino acid position 26.
Verify DCW1 expression vector functions
Before beginning mutagenesis, it was important to test whether the destination vector and target gene would function in our system. We sequence-verified the wild-type DCW1 expression vector pRZ160 and then transformed it into BY240 and selected for growth on SC-His media (selecting for pRZ160). The resulting strain was grown on 5-FOA to verify that the strain could lose the original pCU-DCW1 plasmid and survive with the new DCW1(His) plasmid, pRZ160. This confirms that the DCW1 promoter and DCW1 ORF functioned in S. cerevisiae and would be suitable substrates for mutagenesis.
Transposition reaction and processing pool
A detailed transposition and processing protocol is in File S1. In short, TnsA, TnsB, and TnsC A225V enzymes (purified as described in were used in an in vitro reaction, mobilizing the Tn7-tag cassette from a Tn7 donor vector into a target vector containing the DCW1 ORF or the CgSIR3 ORF. The mutagenized plasmids were recovered by transforming into E. coli MegaX cells and selecting for appropriate drug resistance. The DCW1 ORF was mobilized using Gateway recombination enzymes in a dedicated DCW1 destination vector, creating a mutagenized DCW1 expression pool; likewise, following mutagenesis, the CgSIR3 ORF was mobilized into a corresponding SIR3 destination vector. These expression pools were recovered in E. coli MegaX cells and selected in sequential rounds of Car and Tmp selection. The left end of Tn7 was removed by FseI digestion; the right end of Tn7 and the Tmp R marker were removed by PmeI digestion.
Screening and analysis of Dcw1-FLAG alleles in S. cerevisiae
The final DCW1-FLAG plasmid pools were transformed into S. cerevisiae and grown on SD-His plates at 30°for 2 days. Transformants on the SD-His plates were replica-plated to 5-FOA plates and grown at 37°for 1 day and then re-replica-plated to 5-FOA plates and grown for 1 day at 37°. Only cells with functional DCW1-FLAG alleles will grow; those with nonfunctional DCW1-FLAG alleles will die on 5-FOA because of counterselection against the pCU-DCW1 plasmid.
We performed colony PCR on functional FOA R transformants to qualitatively determine where the FLAG was inserted within the DCW1 ORF. The PCR to determine FLAG insertion position used primers 2766 and 6244 or primers 5160 and M13F. We also performed PCR with 2766 and a primer (5626) that reads out of Tn7L; any isolates that gave a PCR product were eliminated from further study. A subset of isolates predicted to have different sites of insertion (based on PCR product size) were sequenced with primer 6244 to identify the exact placement of the FLAG tag. We screened 276 isolates by colony PCR, sent 48 isolates for sequencing, and found 10 unique DCW-FLAG alleles with internal insertions.
For the 10 unique isolates, functional DCW1-FLAG plasmids were isolated from S. cerevisiae and recovered by transformation into E. coli (Hoffman 2001) . The plasmids were individually retransformed into BY240, and their growth phenotype was confirmed. These 10 clean functional strains were used for subsequent growth analysis and for Western blots. The 10 clean DCW1-FLAG strains, the DCW1-HA strain, and control strains were streaked onto YPD, and complementation was tested again on 5-FOA (at 39°, 37°, and 30°), SC-Ura, SCHis, and YPD plates at 30°. After growth for 2 days, pictures were taken on an Alpha Imager and growth was compared ( Figure 4) .
Construction of C. glabrata SIR3 Gateway vectors
The C. glabrata SIR3 destination vector was constructed by PCR-amplifying the regions flanking the SIR3 ORF from strain CBS138 (Dujon et al. 2004) . Primers 3220 and 3221 were used to amplify the 59 flanking region; primers 3222 and 3223 were used to amplify the 39 flanking region. These PCR products were subcloned into a Gateway backbone on either side of a ccdB cassette, using the restriction sites present in the primers. This Gateway backbone contains replication origins and and an Amp R cassette for selection in E. coli, as well as a CEN/ ARS and Nat R marker for maintenance and selection in C. glabrata. The SIR3 entry vector was created by PCRamplifying the SIR3 ORF from C. glabrata strain BG2 (Cormack and Falkow 1999) using primers 4470 and 4484 and subsequently introducing the ORF into the Gateway backbone pDONR201 using a Gateway BP reaction (Life Technologies). We note that there are three polymorphisms in the SIR3 ORF, relative to the CBS138 sequence, but these do not affect function, as a wild-type SIR3 expression vector generated from this ORF allele (pRZ47) complements a sir3D defect in C. glabrata. Schematic drawings of the SIR3 entry vector and destination vector are shown in Figure S2 .
Microscopy of Sir3-GFP strains
Eight C. glabrata strains carrying various Sir3-GFP alleles, as well as a negative control strain carrying an untagged Sir3 vector, were grown to stationary phase in liquid YPD+Nat. Cells were washed in PBS and resuspended in PBS, and 5 ml of the cells was mounted on a slide. Images were taken using a Zeiss Axioskop microscope with a 1003 objective. The captured images are automatically displayed with optimized brightness and contrast settings in Image J; these maximum and minimum values for the entire captured image are listed in Figure 8 . Image J software was used to adjust the constrast to the same settings for all images, thereby allowing more direct comparison of GFP brightness across all images. The adjusted contrast images were converted to 8-bit images, cropped, and resized using Adobe Photoshop and Adobe Illustrator.
S. cerevisiae protein preparation and Westerns S. cerevisiae strains carrying various DCW1-FLAG plasmids, or a wild-type DCW1 untagged plasmid (negative control), were grown in SD-His media to mid-log phase (OD 600 between 0.1325 and 0.2325). Cells were pelleted by centrifugation and stored at 280°. Cell pellets were weighed on a microscale; these weights were used later to normalize loading between strains. Lysates were prepared similar to the method of Frieman and Cormack (2004) .To prepare lysates, resuspend cell pellets in 50 mM Tris (pH 8.0) supplemented with protease inhibitors (Roche, 04693132001) and lyse with glass beads using a FastPrep (Bio101 Thermo Savant) (three times: 45 sec, 6.5 speed, ice 1 min between beatings). Supernatants were transferred to clean tubes, and beads were washed in 400 ml Tris (pH 8.0) + protease inhibitors and combined with an earlier fraction (800 ml lysate total). Lysates were clarified by centrifugation at 13,000 3 g, 10 min, 4°in a microfuge. Supernatant was saved as the "cytoplasmic" fraction. The pellet was resuspended in 1 ml 50 mM Tris (pH 8.0) + 2% SDS and boiled for 20 min, vortexing to mix every 10 min. After centrifugation (13,000 3 g, 10 min, 4°), the supernatant was saved as the "plasma membrane" fraction. The remaining pellet material was resuspended, washed in Tris+SDS, boiled, and centrifuged (as above) three additional times; supernatants were discarded. The pellet was washed four times (twice in 1 ml, twice in 500 ml) in 50 mM Tris + protease inhibitors and spun as before. The pellet was washed once in 500 ml 33 mM potassium phosphate and then resuspended in 100 ml 33 mM potassium phosphate + 60 mM b-mercaptoethanol; this is the "cell-wall" fraction.
Material from each fraction was loaded onto an SDS-PAGE gel; volumes were normalized across strains using pellet weights. Proteins were transferred to Immobilon-P membrane and immunoblotted using antibodies as indicated. Mouse monoclonal a-FLAG (F1804, Sigma) was used at 1:2000 diluted in TBS+3% milk; a-Pgk1 (A6457, Molecular Probes) was used at 1:1000 in TBS+3% milk. Both of these were used in conjunction with a-mouse HRP-linked (Cell Signaling) secondary antibody at a 1:2000 dilution. The a-Dcw1 polyclonal antibody was raised against the peptide VELDLDNYESLQ, representing amino acids 22-33 in the Dcw1 protein (Covance, Princeton, NJ). For Dcw1 detection, the a-Dcw1 primary antibody was diluted at 1:1000 in TBS+3% milk, and the secondary antibody was a 1:5000 dilution of a-rabbit HRP-linked antibody (Cell Signaling). Amersham's ECL kit (RPN2132) was Figure 1 Schematic of the Tn7-FLAG construct. Areas indicated by red are Tn7 left and right ends. The 33FLAG epitope tag is indicated by black. The gray area is the dhfr gene, which confers resistance to trimethoprim (Tmp R ). Restriction sites of interest are indicated above the schematic.
used for chemiluminescent detection; the a-FLAG and a-Pgk1 blots were exposed to film for 5-10 min; the a-Dcw1 blots were exposed for 45 min.
C. glabrata protein preparation and Westerns C. glabrata strains carrying different Sir3-GFP plasmids or a wild-type SIR3 untagged plasmid (negative control) were grown in YPD+Nat media to log phase (OD 600 between 0.5 and 0.635). Cells were pelleted by centrifugation and stored at 280°. Lysates were prepared in a urea lysis buffer (Ubersax et al. 2003) , supplemented with protease inhibitors (Roche, 11836170001) . Proteins were separated on a 3-8% Tris-acetate SDS-PAGE gel (Nupage) and transferred to an Immobilon-P PVDF membrane. A polyclonal a-GFP primary antibody (Abcam, ab290) was used at 1:5000 dilution in PBST+5% milk; the a-rabbit HRP-linked secondary antibody (GE Healthcare, NA934V) was used at a 1:5000 dilution. Chemiluminescent detection was performed using the Amersham ECL kit (RPN2132).
Viability selection and sequence analysis of functional tagged SIR3 alleles in C. glabrata SIR3 was mutagenized four separate times, using the Tn7-bio, Tn7-myc, Tn7-mEOS2, or Tn7-GFP donor vectors. After processing the mutagenized plasmid pools to remove leftover Tn7 sequence, the final Sir3-bio, Sir3-myc, Sir3-mEOS2, and Sir3-GFP pools were transformed into C. glabrata strain CGM293, and transformants were selected by growth on YPD+Nat plates for 2 days at 30°. Strain CGM293 carries URA3 integrated into a subtelomeric location, where it is subjected to Sir3-dependent transcriptional silencing. Only cells that carry a functional tagged version of Sir3 have intact subtelomeric silencing, thus silencing the URA3 gene at the telomere and permitting growth on plates containing 5-FOA. To select functional clones of Sir3, the YPD+Nat plates were replica-plated onto 5-FOA plates and grown for 2 days at 30°. For the Sir3-myc transformation the pool was outgrown in liquid YPD+Nat prior to plating. This pool showed skewed representation of particular insertion sites. Subsequently, for the other three pools, the transformations were plated directly onto YPD+Nat plates, and these pools show a more even representation of different functional alleles. As with the DCW1 screening, we performed colony PCR to qualitatively determine where the tag had inserted into SIR3. Judging from these PCR product sizes, plasmids carrying SIR3 with a range of insertion sites were sent for sequencing to determine the exact position of the tag within SIR3 (Table S6 and Table S7 ). Figure 2 Overview of mutagenesis work flow. An in vitro mutagenesis reaction introduces the Tn7-FLAG transposon randomly throughout the target entry vector (here, DCW1). Mutagenized DCW1 plasmids are selected on the basis of Tmp R and Kan R . To isolate only those versions that have a Tn7-FLAG inserted in DCW1, and not in the backbone, a Gateway LR reaction is used to mobilize the DCW1 gene into a DCW1 destination vector. After transformation into MegaX E. coli cells and selection with Tmp and Car, only expression vectors that have a mutagenized DCW1 gene should remain. Restriction digests are used to remove the bulk of the transposon: FseI removes the Tn7L end; PmeI removes the Tmp R cassette and Tn7R. After this series of digestions, the pool will consist of DCW1 expression vectors with a 33 FLAG epitope inserted randomly, in either direction, in the DCW1 gene.
Results

Transposon design
The Tn7-FLAG transposon ( Figure 1 ) is based off the miniTn7 design (Biery et al. 2000) , using truncated Tn7 left and right (Tn7L and Tn7R) ends. The Tn7L region is 206 bp long, whereas the Tn7R region is 71 bp long. Previous research has shown the Tn7 ends can accommodate PmeI sites and still mobilize during in vitro transposition reactions (Biery et al. 2000) . Here, we engineered FseI and PmeI sites at the distal Tn7 transposon ends to facilitate removal of the bulk of the transposon sequence using restriction digests after the mutagenesis occurs (see later description). These restriction enzymes have 8-bp restriction sites, which occur rarely in the DNA genome sequence. The Tn7-FLAG construct contains two FseI sites, which flank the Tn7L end; two PmeI sites flank a trimethoprim resistance (Tmp R ) cassette and the Tn7R end. PmFseI digestion, therefore, removes the left end of the transposon, while PmeI digestion removes the right portion of the transposon. The transposon contains a 33 FLAG epitope tag, located between the internal FseI and PmeI sites. The entire Tn7-FLAG construct is carried on the plasmid pRZ101, which serves as a Tn7 donor plasmid. The pRZ101 backbone includes a kanamycin resistance marker (Kan R ) and replicates using a R6Kg ORI. This ORI functions only in E. coli cells containing the P protein, encoded by the pir gene (Kolter et al. 1978; Haldimann et al. 1996; Metcalf et al. 1996) .
During Tn7 mutagenesis, the Tn7 transposase, containing TnsA and TnsB subunits, creates double-strand breaks at the Tn7 ends, releasing the Tn7-FLAG cassette from pRZ101. TnsC A225V mediates insertion of the Tn7-FLAG cassette into a variety of targets with essentially no sequence specificity (Green et al. 2012) . During host-mediated repair of the insertion product, a 5-bp duplication is introduced at the insertion site. The epitope tag is positioned within Tn7-FLAG so that it will be translated correctly in only one reading frame after subcloning to excise transposon sequences. All other reading frames contain STOP codons. Thus, five of six transposon mutants are expected to be nonfunctional as a consequence of the epitope tag being out of frame and generating an internal stop codon. After all mutagenesis and processing of the transposon mutants, the Tn7-FLAG cassette introduces 159 bp into the target (including the 5-bp duplication), resulting in a 53-amino-acid insertion internally fused into the target protein.
Tn7-FLAG can be easily adapted to introduce other epitope tags. Unique AscI and XbaI sites flank the FLAG cassette, and these sites can be used to change the epitope tag to any other tag of interest. In our own work, we generated Tn7-6His, Tn7-myc, Tn7-GFP, Tn7-mEOS2, Tn7-biotin, and Tn7-33HA donor plasmids, all of which have been confirmed to mobilize during in vitro transposition reactions (not shown).
Methodology overview
The in vitro mutagenesis method to introduce internal epitope tags is outlined schematically in Figure 2 . To illustrate the utility of this system, we chose to internally tag the protein Dcw1, a GPI-anchored protein, which cannot be functionally tagged at either the N-or C-terminus. The method consists of three separable steps, all of which are carried out in vitro, with recovery of reaction products by transformation into E. coli. First, transposition is used to generate a pool of Tn7 insertions throughout the plasmid carrying the gene to be tagged. Second, Tn7 insertions within the ORF are isolated by a Gatewaymediated recombination step. Third, this pool of Tn7-mutated ORFs is treated with restriction enzymes to remove essentially all transposon sequences, leaving just the introduced protein tag.
Transposition: Using a target plasmid containing the DCW1 ORF cloned into a Gateway entry vector, we performed an in vitro mutagenesis reaction with recombinant Tn7 transposase proteins. The reaction mobilizes the Tn7-FLAG cassette from the Tn7 donor plasmid into the DCW1 target plasmid. This creates a pool of mutagenized DCW1 entry vectors. This pool is transformed into highly competent E. coli DH10 cells and selected for both Tmp R and Kan R in liquid culture. The use of DH10 cells selects against the Tn7-FLAG donor plasmid, as this plasmid's R6Kg ORI will not replicate in DH10 cells. Double drug selection selects against unmutagenized DCW1 entry Colony counts, as plated after recovery during transformation, prior to drug selection in pool. Cells were diluted appropriately to prevent a lawn of growth and plated onto media as indicated. Numbers in the table are calculated to represent the number of colonies in the full transformation resistant to the given drug. ND, not determined. a xpC colony counts were revised; see File S3 and Table S5 . Fold coverage was calculated by comparing the number of colonies from the indicated drug selection to the size of the DNA available for mutagenesis (File S2).
vectors. Thus, after growth overnight in Tmp and Kan, only cells carrying mutagenized DCW1 entry vectors should survive.
Isolation of mutagenized ORFs by Gateway recombination:
The pool consists of plasmids that have a transposon inserted in the DCW1 ORF as well as plasmids where the transposon is inserted in the plasmid backbone (and which have an unmutagenized ORF). To isolate only those ORFs that have been insertionally mutagenized, we used Gateway recombination to mobilize the DCW1 ORF from the entry vector into a DCW1 destination vector ( Figure 2 ) to generate what we refer to as the expression pool. The DCW1 destination vector contains DCW1 promoter and terminator regions, flanking a ccdB cassette; it also contains replication origins and markers for propagation and selection in both E. coli and yeast. This DCW1 expression pool was recovered by transformation into E. coli DH10 cells. Expression pool plasmids, with the transposoncontaining DCW1 ORF cassette, confer resistance to both Tmp and Car. We found that this double selection was maximally effective if we performed the drug selections sequentially (data not shown); accordingly, the transformed cells were initially selected only for carbenicillin resistance (Car R ), which selects for all destination vectors carrying a mutagenized or unmutagenized DCW1 ORF. Entry vectors and destination vectors that did not recombine are selected against based on the Car R and ccdB counterselectable cassette, respectively. After selecting for Car R , plasmid DNA is recovered from the expression vector pool and transformed again into E. coli DH10 cells, this time selecting for Tmp R . After growth in Tmp, only cells carrying DCW1 expression vectors with a Tn7-FLAG cassette remain. Note that the Tn7-FLAG may be inserted in any reading frame at this point, as the pool of mutants has not been screened for function in yeast yet.
Removal of transposon sequences:
Removal of the bulk of the transposon, leaving only the epitope tag, requires two restriction digests and ligation steps. These cloning steps are performed on the pooled DNA, allowing for easy processing of the entire insertion library. Digestion with FseI releases the Tn7L end from each plasmid, which is then recircularized by ligation. This "-Tn7L" pool of plasmid DNA is transformed into E. coli, and the liquid culture is treated with Tmp and Kan simultaneously. This second round of Tmp selection is possible since the Tn7R end and dhfr gene remain in the construct and selects against any residual unmutagenized DCW1 expression vectors that have escaped the previous selection step. Next, a PmeI digest is used to remove the dhfr (Tmp R ) gene and the Tn7R end ( Figure 1 ). After intramolecular ligation, the plasmid pool is transformed into E. coli and selected for Car R . The DNA isolated from this pool contains mutagenized DCW1 expression vectors with the 59-aa FLAG epitope inserted in any of the six reading frames.
Monitoring pool sizes and complexity
Transposition efficiency was monitored by plating on various selective media. Transformation of our mutagenesis reaction resulted in 5 3 10 6 Kan R colonies, representing all plasmids whether mutagenized or not. Of these, 2 3 10 5 (4%) contained transposon insertions (Tmp R Kan R ) ( Table 1 ). This represents a 47-fold coverage of all possible insertion sites for the plasmid (File S2). The efficiency of Gateway LR mobilization, as well as the fraction of ORFs carrying the Tn7-flag, was estimated by scoring for Car and Tmp resistance (File S3). We determined that the initial expression pool (xpC) contained 2.5 3 10 5 Tmp R Car R independent recombinants (Table 1) . Thus, the majority of the pool complexity is maintained in the expression pool. For subsequent steps, FseI digestion and PmeI digestion, we recovered at least 4 3 10 6 transformants, again ensuring that pool complexity was maintained through different cloning steps.
Complexity of the pool was qualitatively assessed using restriction digests of pool DNA at each step of the processing (File S4). Additionally, the plasmids from a subset of the final mutagenized expression pool were isolated and sequenced with primer 6244 to assess the distribution of Tn7 insertion sites in the plasmid. From 48 sequenced isolates, we found 29 had FLAG inserted in the reverse orientation (representing 18 unique sites) and 19 had FLAG inserted in the forward direction (representing 18 unique sites). For two nucleotide positions, we isolated FLAG insertions in both the "forward" and the "reverse" orientations in different isolates.
Selection for functional clones in yeast
The final DCW1-FLAG pool was transformed in batch into S. cerevisiae to screen for functional clones. Mutations in DCW1 and the related gene DFG5 are synthetically lethal in S. cerevisiae (Kitagaki et al. 2002) . We use the strain BY240, which is a dcw1D dfg5D strain carrying a wild-type copy of DCW1 on a URA3-marked plasmid (pCU-URA3). The plasmid backbone of the DCW1-FLAG expression pool contains a yeast CEN/ARS sequence and a HIS3 marker for selection. After transforming the DCW1-FLAG pool into BY240, we selected against the original wild-type pCU-URA3 plasmid by growth in the presence of Figure 3 Location of FLAG insertions in functional DCW1-FLAG alleles. Domain structure of Dcw1 is based on predictions from ELM. The locations of FLAG insertions within the functional DCW1-FLAG alleles used in subsequent experiments are indicated by hash marks above the diagram. Dcw1 is 499 amino acid residues in length.
5-5-FOA. Only strains transformed with a functional DCW1-FLAG allele will grow on 5-FOA plates. We performed the 5-FOA selection at 37°; the elevated temperature is a mild cellwall stress and ensures that any cells that grow have a fully functional DCW1-FLAG allele. We screened 100,000 transformants, of which 5% had functional versions of DCW1-FLAG (data not shown).
Transformants were first screened for presence of a FLAG insertion using whole-cell PCR (data not shown). Products had a range of sizes, representing FLAG insertions across the DCW1 ORF. A subset of these was chosen for further characterization. Plasmids carrying functional DCW1-FLAG alleles were isolated from individual S. cerevisiae transformants and recovered in E. coli. The location of the FLAG insertion within the DCW1 ORF was determined by sequencing. A number of unique insertion sites were identified, as illustrated on the schematic shown in Figure 3 . The majority of insertions were, as expected, in the ORF. In addition, several isolates were identified in which the FLAG was inserted just upstream or downstream of the DCW1 ORF in the sequence between the Gateway recombination sites and the ORF in the expression vectors (data not shown). We found that the Gateway attL1 and attL2 recognition sequences, required for mobilization of the DCW1 ORF into the destination vector, are partially permissive such that certain Tn7-disrupted attL1 and attL2 sequences still, surprisingly, function in the Gateway reaction. These few insertions, therefore, have the epitope outside of the ORF sequence and represent contamination in the overall library.
Unique DCW1-FLAG plasmids were retransformed into S. cerevisiae strain BY240, and function was confirmed by testing for growth on 5-FOA plates ( Figure 4 ). All internally tagged DCW1-FLAG isolates tested grew robustly on 5-FOA at temperatures up to 39°, confirming that the DCW1-FLAG alleles are fully functional. The DCW1-HA 26 allele showed reduced growth on 5-FOA at 30°and no growth at 37°and 39°, indicating that it is a partially functional hypomorphic allele. Figure 4 Select DCW1-FLAG isolates rescue synthetic lethality of dcw1D dfg5D mutants. Each yeast strain was grown on 5-FOA at three temperatures to test for Dcw1 function. Strains were also grown on YPD to verify overall viability. The positions of each strain are shown in the schematic at the top. Three control strains, labeled here as N, C, and WT, were streaked onto each experimental plate. Strain "N" is a negative control: the parental strain BY240, a dcw1D dfg5D pCU-DCW1 strain derived from BY4742. Strain "V" is another negative control: BY240 transformed with an empty (His) vector, pRZ159. The "WT" strain is a positive control: strain BY240 transformed with a wild-type DCW1 (His) plasmid. BY4741 and BY4742 are DCW1 DFG1 ura3D strains used to derive other strains. dfg5D and dcw1D are deletion mutants derived from BY4741 from the yeast knockout collection . The strain BY240 transformed with a DCW1-HA 26 (His) plasmid is in the position labeled "HA 26 ." The remaining strains are BY240 transformed with various DCW1-FLAG (His) plasmids and labeled to indicate the amino acid position of the FLAG insertion.
Detecting FLAG by Western blot
To verify that the FLAG epitope introduced into Dcw1 is detectable by Western analysis, we monitored Dcw1-FLAG protein levels in our strains carrying functional DCW1-FLAG clones. Cytoplasm, plasma membrane, and cell-wall fractions were isolated from log-phase cultures of each strain. Dcw1 is a membrane-bound GPI protein (Kitagaki et al. 2002) , and abundant FLAG signal is easily detectable in the cell membrane fraction in 8 of the 10 strains expressing Dcw1-FLAG alleles, consistent with the fact that these are fully functional Dcw1-FLAG alleles ( Figure 5 ). Untagged Dcw1, which would not be visible on the a-FLAG immunoblot, is predicted to have a molecular weight of 49.5 kDa. Dcw1-FLAG fusion proteins are expected to have a molecular weight of 55 kDa. However, mature Dcw1 is glycosylated, and previous studies have shown that Dcw1-HA has an apparent molecular weight of 80 kDa (Kitagaki et al. 2002) , similar to what we observe in Figure 5 . For three alleles, the FLAG insertion (at residue 5, 6, or 11) is predicted to disrupt the signal sequence ( Figure 3 ). For two of these three, Dcw1-FLAG 5 and Dcw1-FLAG 6 , the immunoblot showed no signal, and for one, Dcw1-FLAG 11 , the protein was detectable in the membrane fraction, but its molecular weight is lower than expected (60 kDa, instead of 80 kDa).
To confirm that the localization observed of the Dcw1-FLAG fusion proteins represents true localization of untagged Dcw1, we also performed immunoblots using these same cellular fractions with an a-Dcw1 antibody raised against a peptide portion of native Dcw1 ( Figure S1 ). The signal is much fainter than what we observed using a-FLAG antibodies; importantly, the Dcw1-FLAG fusion proteins show similar size distributions using both the anti-Dcw1 and anti-FLAG antibodies.
Mutagenesis of a second target gene, C. glabrata SIR3
The demonstrate the generality of the tagging methodology, we used the same approach to mutagenize the SIR3 gene of Candida glabrata, which is required for silencing of sub-telomeric regions of the C. glabrata genome (De Las Penas et al. 2003) . Schematic diagrams of the Sir3 Gateway constructs are shown in Figure S2 . We used four different Tn7 derivatives (Tn7-myc, Tn7-GFP, Tn7-mEOS2, Tn7-biotin) to generate libraries of Tn7 insertions with between 3 and 6 3 10 5 independent insertions in each pool. Functional tagged alleles were identified by complementation of a sir3D strain. We sequenced the insertion sites for fully functional alleles, identifying tag insertion sites distributed across the ORF ( Figure 6 , Table S6 , and Table S7 ). We chose to further characterize eight GFP-tagged SIR3 alleles, which complement for the telomeric silencing defect ( Figure S3 ), representing insertions sites distributed across the ORF. By Western analysis, all eight were expressed at approximately similar levels (Figure 7 ). For all eight alleles, Sir3-GFP was localized in puncta, as has been reported previously for wild-type Sir3 protein in S. cerevisiae (Cockell et al. 1995) (Figure 8 ).
Discussion
Here we describe a robust system for creating a library of internally tagged target protein constructs. This mutagenesis is carried out in vitro, and all subsequent steps of selecting for insertional mutants and removing excess Tn7 sequence are carried out on the bulk pool in vitro. This batch processing greatly reduces the effort in maintaining and screening the thousands of possible mutants.
As proof of principle, we mutagenized a target gene, DCW1, to saturation, introducing a 33 FLAG epitope throughout the ORF. Screening in yeast identified fully functional tagged DCW1-FLAG alleles, of which we chose 10 for further analysis. All 10 DCW1-FLAG alleles that we created proved to have wildtype levels of function when assayed for growth at elevated temperatures.
Monitoring the distribution of Dcw1 in fractionated cell lysates by Western blot illustrated that the available FLAG antibodies were more sensitive than antibodies directly raised against a peptide in Dcw1. The majority of alleles had a subcellular distribution similar to the wild-type protein-primarily in the membrane fraction, consistent with its proposed function (Kitagaki et al. 2002) . Two alleles, Dcw1-FLAG 5 and Dcw1-FLAG 6 , were not detectable in any cell fraction in the a-FLAG Western blots. We suspect that the FLAG tag, located in the signal sequence in these two alleles, may have been cleaved off Figure 5 Western blot analysis of Dcw1-FLAG expression in S. cerevisiae. (Top) Anti-FLAG immunoblots of S. cerevisiae strains expressing Dcw1-FLAG alleles, representing the cytoplasmic, plasma membrane, and cell-wall fractions from each strain. Material from 7.5 3 10 5 cells is loaded for each strain in each fraction. Wells are labeled with the amino acid site of the FLAG tag within Dcw1. (Bottom) Anti-Pgk1 immunoblot of the cytoplasmic and plasma membrane fractions from strains carrying Dcw1-FLAG alleles. Cytoplasmic material from 3.75 3 10 5 cells is loaded for each strain. Membrane material from 3.5 3 10 5 cells was loaded for each strain during normal protein trafficking. In the case of Dcw1-FLAG 11 , the protein was detected in Western blots, but appeared smaller than the expected size ( Figure 5 ). This apparent size difference could be due to truncation or incomplete post-translational glycosylation. We note that introduction of internal epitopes may still alter protein function. However, if multiple functional tagged alleles have the same phenotype and show the same subcellular distribution -as we observed for 7 of 10 alleles-this increases confidence that they reflect wild-type function.
We also mutagenized the C. glabrata SIR3 gene and isolated 126 functional, unique internally tagged alleles (four different tags). By Western analysis, GFP internally tagged proteins were expressed at similar levels, and all showed a punctate distribution similar to that documented for Sir3 in S. cerevisiae. Since the tranposon insertion is random and generates many nonfunctional insertions, the utility of the method depends on a robust screen for functional alleles. This can be an assay for viability (as for DCW1). For Sir3, the assay for function was not viability but growth in the presence of 5-FOA as a measure of transcriptional silencing of a subtelomeric URA3 gene. For DCW1 and SIR3, 5% of insertions were functional, suggesting that, for some proteins at least, functional alleles could also be identified by manual screening of a relatively small number of insertions.
For DCW1, the functional alleles had FLAG insertions clustered in a few regions of the gene, including in the central globular glycosyl hydrolase domain (identified by protein BLAST and ELM motif finding) (Kitagaki et al. 2002) . For SIR3 as well, functional insertions for all four tags were found across the ORF, including insertions in N-and C-terminal predicted globular domains. It would have been difficult to predict that these regions would tolerate insertions solely based on bioinformatic modeling of the protein structure. Unlike other epitope-tagging systems (Khmelinskii et al. 2011; Ramsden et al. 2011) , this Tn7-based system requires no prior knowledge of permissive sites to introduce tags in the POI. The efficient in vitro mutagenesis and cloning steps allow researchers to create and recover an unbiased set of tagged versions of a target gene, which can then be screened for function.
The system of Tn7-based epitope tagging that we describe should be broadly useful. We have described the application to epitope tagging of an essential yeast gene. However, several aspects of the methodology make it suitable to tagging of proteins in virtually any system. First, once Gateway vectors are constructed, mutagenesis, cloning, and screening (in yeast) takes 2-3 weeks total. Second, the mutagenesis is carried out in vitro, and Tn7 has minimal insertion sequence bias. Third, the insertions in the ORF are isolated without regard to function of those insertions. Fourth, the library of tagged proteins is generated in final form in E. coli, obviating the need to remove transposon sequences in the cell type where functional screening is done. Rather, the final library can simply be introduced into the appropriate cell type and screened directly.
Since a major use of transposon epitope-tagging methods is to generate fully functional tagged versions of the POI, it is imperative that the screening be done only on mutagenized ORFs since any untagged wild-type alleles in the pool would pass the functional screen. In the highly useful Tn5-based system, TAGIT, the selection for tagged alleles is by presence of the marker gene carried in the transposon. This allows introduction of the mutagenized library into the cell where screening is carried out; at this stage the transposon sequences are removed by expression in the cell of Cre recombinase. Our Figure 6 Distribution of functional tagged alleles of C. glabrata SIR3. (Top) Linear representation of the C. glabrata Sir3 protein (1088 residues). The gray areas are predicted globular domains (by ELM), which have been found to have roles in associating with histones (N-terminal domain) and Sir3 dimerization (C-terminal domain). In the schematics below, a black line is located at the position for each unique insertion site identified from among the functional Sir3-bio, Sir3-myc, Sir3-mEOS2, and Sir3-GFP pools. (Bottom) Schematic overlays all sites at which a functional tagged Sir3 was identified. The color of the line indicates the number of mutagenesis pools in which the particular insertion site was identified; light blue indicates that the site was identified in only one pool; black indicates that it was found in all four mutagenesis pools.
method provides an alternative to this approach. Insertions in the ORF are efficiently isolated from nonmutagenized ORFs by Gateway-mediated recombination. This step is highly efficient and can be carried out in batches, permitting construction of a library of tagged ORFs comprising tens or hundreds of thousands of independent insertion events. Subsequent efficient restriction digestions of the pool to remove the left and right ends of the transposon result in a complex pool of tagged ORFs in an appropriate expression vector. This library can then be directly screened for function as dictated by function of the POI, without the need to express recombinase enzymes in the target cell. As a caveat, we note that we recovered a small number of functional expression plasmids where the epitope had inserted between the Gateway recombination sites and the ORF (data not shown); it appears that the attL1 and attL2 sites are somewhat permissive for insertions. This leaves the target ORF unmutagenized, and our current plasmid architecture makes it impossible to eliminate these extraneous plasmids from the pool.
An advantage of this Tn7-based method over other transposon systems is the very limited amount of transposonderived sequence left in the insertion site. In our method, the FseI and PmeI sites are engineered to be present within three bases of the transposon end, and following excision, there are only 22 nucleotides (essentially the FseI and PmeI sites) in addition to the epitope tag present at the insertion site. This increases, we would argue, the likelihood of identifying functional epitope insertions since it limits the amount of extraneous sequence shared by all insertions to a few amino acids.
Finally, the method in principle could be used for analysis of proteins in many different organisms. The mutagenesis of the cloned gene is done in vitro, and mobilization into the expression vector exploits Gateway recombination. This can be adapted most easily to any system for which Gateway-modified expression vectors exist. We suggest that the method will be useful in a range of systems, including model eukaryotic systems like S. cerevisiae as well as mammalian systems.
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The same cell fractions used in Figure 5 were run on new SDS-PAGE gels and probed with an -Dcw1 antibody. Signal was detected using chemiluminescence, and film was exposed for 45 minutes. Material from 7.5x10 5 cells is loaded in each strain in each fraction. Wells are labeled with the amino acid site of the FLAG tag within Dcw1. We note the apparent size of Dcw1 in the plasma membrane is larger than what we observed with -FLAG antibodies, but the overall pattern is consistent with the -FLAG Westerns shown in Figure 5 . Figure S2 . Gateway constructs used for mutagenesis of C. glabrata SIR3 These schematic drawings represent the Gateway entry vector and destination vector used during the mutagenesis of C. glabrata SIR3, as represented in Figure 2 in the manuscript. Figure S3 . Sir3-GFP alleles complement for growth on 5-FOA C. glabrata strains carrying various Sir3-GFP alleles were grown overnight in YPD+Nat media in 96-well plates. Yeast were diluted to OD 600 =2 and placed in the left-most well of a new 96-well plate. Ten-fold serial dilutions were made in sterile PBS, and the cells were transferred to a 5-FOA plate using a multi-pin tool. The plate was grown at 30C. We note that the lack of growth for BG3161 in the left-most (densest) dilution is likely due to uneven placement of the pin tool onto the 5-FOA plate. This represents the % of the xpC pool that bears a mutagenized DCW1-FLAG expression vector, and was used to correct the xpC pool size shown in Table 1 of the main paper. Table S6 . Size of SIR3 mutagenesis pools during selection and sequencing Colony counts, as plated after recovery during transformation, prior to drug selection in pool. Cells were diluted appropriately to prevent a lawn of growth and plated onto media as indicated. Numbers in the table are calculated to represent the number of colonies in the full transformation resistant to the given drug. nd = not determined. Fold coverage was calculated by comparing the number of colonies from the indicated drug selection to the size of the DNA available for mutagenesis (Supplemental Note 1). * The Sir3-myc pool was treated differently than other pools. After transformation of the Sir3-myc pool into C. glabrata, the pooled culture was outgrown in YPD+NAT for ~24 hours prior to plating on YPD+NAT. All other tagged Sir3 pools were plated directly onto YPD+NAT plates following transformation and recovery.
Tn used to mutagenize C. glabrata SIR3
Step of processing 1  408  1  413  3  414  2  458  5  475  1  507  2  536  1  2  543  1  544  1  546  1  548  1  550  1  551  1  552  2  553  1  573  2  1  574  1  575  1  590  2  629  1  645  1  667  1  1  668  1  669  1  712  1  1  713  1  716  2  1  1  717  1  1  721  1  1  749  1  767 1 Table S7 . Insertion sites of select in-frame complementing tagged Sir3-alleles
Complementing clones from the mutagenized Sir3 pools were analyzed with colony PCR to qualitatively determine the location of the epitope tag within the SIR3 ORF. PCR products from a subset of these complementing clones were sequenced and the precise location of the tag insertion was identified. Each of the 107 unique locations within Sir3 where a tag was found in a functional allele is listed in the "insertion site" column, based on the amino acid of insertion. The final two insertion sites listed are downstream of the Sir3 STOP codon. The remaining columns list the number of complementing clones from each mutagenized pool found at a given insertion location. In total, the epitope tag was located in frame in 65 Sir3-myc, 52 Sir3-bio, 46 Sir3-mEOS2, and 47 Sir3-GFP complementing clones.
File S1 Protocol
In vitro Transposon Mutagenesis for Introduction of Internal Epitope Tags
REQUIRED REAGENTS
Purified TnsA, TnsB, and TnsC A255V enzymes 3, 4 TnsA stock = 150ng/l in Storage Buffer A TnsB stock = 200ng/l in Storage Buffer B TnsC A255V stock = 500ng/l in Storage buffer C Tn7 donor vector: pRZ101 (Tn7-FLAG donor vector). Dilute to 25ng/l in 10mM Tris pH8.0 Entry vector of target gene: DCW1 entry vector. Dilute to 50ng/l in 10mM Tris pH8.0 Invitrogen MegaX DH10B T1R electrocompetent E. coli cells 300mM Magnesium Acetate (MgOAc) phenol:chloroform:IAA (25:24:1) (Amresco 0883-100ml) Chloroform 3M Sodium Acetate (NaOAc) 100% ethanol (EtOH) 70% EtOH FseI (New England Biolabs R0588S) PmeI (New England Biolabs R0560S) ApaLI (New England Biolabs R0507S) T4 DNA ligase and buffer (New England Biolabs M0202S) Gateway LR clonase II (Life Techonologies 11791-100) Qiagen Hi-Speed MidiPrep kit (Qiagen 12643) MegaX DH10B T1R Electrocomptent Cells (Life Technologies C6400-03) LB media Oxoid Isosensitest media (Iso) (agar: OXCM0471B, liquid broth: OXCM0473B) Carbenicillin (100mg/ml = 1000x stock) Kanamycin (30mg/ml = 1000x stock) Trimethoprim (5mg/ml in DMSO = 500x stock) ddH 2 O = doubly distilled (MilliQ) H 2 O BUFFERS Use sterile-filtered MilliQ water to make all buffers. If possible, make all buffers in plastic containers; residual detergent on glassware may inhibit the transposition reaction.
Standard buffers 20mM ATP in 125mM Tris pH 7.5 (store at -20C for at most 1 month) 20mM DTT in 125mM Tris pH 7.5 (store at -20C for at most 1 month) 100mM ATP in 250mM HEPES (pH8.0) -for making TnsC storage buffer 1M DTT in 150mM HEPES (pH8.0) -for making TnsA and TnsC storage buffers 1M DTT in 1M Tris pH 7.5 -for making TnsB storage buffer 10mM Tris -for elution of mutagenized plasmid pools from midiprep kit 50% glycerol Tns storage buffers Store at -20C for at most 6 months. We do not recommend refreezing and rethawing of the storage buffers, so store them in small aliquots and discard after use. 2) Aliquot reaction mix into two PCR tubes. Dispense 76l into the "+ enzyme" reaction tube, and 19l into the "-enzyme" reaction tube.
3) Make the enzyme mixture. 5) Add 4l enzyme mix to the "+ enzyme" tube. Flick tube to mix. 6) Add 1l of the buffer mixture to the "-enzyme" tube. Flick tube to mix. 7) Incubate both tubes at 37C for 10 minutes on a PCR heat block. 8) Add 300mM MgOAc to the tubes: For "+ enzyme" reactions, add 4.2l 300mM MgOAc For "-enzyme" reaction, add 1.05l 300mM MgOac 9) Incubate at 37C for 1 hour on a PCR block 10) Incubate at 75C for 5 minutes on a PCR block to heat-kill the enzymes.
Clean-up of transposition reactions
11) Transfer "+ enzyme" and "-enzyme" reactions to 1.5ml microfuge tubes. Bring the volume of each up to 100l. 12) Add 100l phenol:chloroform:IAA. Vortex to mix. 13) Spin 5 minutes, 4C, 13500 rpm in a microfuge. Remove and discard organic (bottom) layer. 14) Add 100l chloroform. Vortex to mix. 15) Spin 5 minutes, 4C, 13500rpm in microfuge. Transfer aqueous (top) later to a new 1.5ml microfuge tube. 16) Add 10l 3M NaOAc. Add 220l ice-cold 100% EtOH. Chill at -20C for 15 minutes. 17) Spin 15 minutes, 4C, 13500 rpm in microfuge. Discard supernatant. 18) Wash DNA pellet with 500l ice-cold 70% EtOH. 19) Spin 5 minutes, 4C, 13500 rpm in microfuge. Discard supernatant. Allow pellet to air dry. 20) Resuspend DNA pellets in desired volume of 10mM Tris pH 7.5. For "+ enzyme" reactions, use 8 l Tris pH 7.5 For "-enzyme" reaction, use 4 l Tris pH 7.5 21) Optional: Cleaned transposition reactions may be stored at -20C prior to transformation.
Transformation of transposition reactions
Transform cleaned transposition reaction DNA into Invitrogen MegaX DH10B T1R electrocompetent E. coli cells. One set of steps is described for the "+ enzyme" reactions, another for "-enzyme" reactions. They can be performed in parallel, but are separated here for clarity. 26B) Recover at 37C for 1 hour 27B) Plate 150l (0.1% of total cells) onto three types of selective media -LB+Kan, Iso + Tmp, and Iso+Tmp+Kan 28B) Add 150l of Kan (30mg/ml stock) and 300l Tmp (5mg/ml stock) to the flask. 29B) Grow plates and culture overnight at 37C.
30) The following morning, count the colonies growing on each plate. Calculate the number of independent transformants in your "+ enzyme" pools. 31) Make a glycerol frozen stock of the "+ enzyme" overnight culture. Store at -80C. 32) Pellet the remainder of the "+ enzyme" overnight culture in a 250ml conical tube. Spin 15 minutes at 3000 rpm.
Pellet can be stored at -20C, or continue to step 33 directly. 33) Purify the DNA from the "+ enzyme" culture cells using a Qiagen HiSpeed Midiprep Kit. Elute in 1ml 10mM Tris. This is the mutagenized DCW1*FLAG entry vector pool (ep). 
Gateway LR mobilization to create expression pools
Linearizing the mutagenized entry pool increases the efficiency of the Gateway LR reaction. Additionally, it minimizes the amount of Kan-marked plasmid that is present in the subsequent pools.
Linearize mutagenized DNA pool 1) Identify a restriction enzyme that cuts only in the backbone of the mutagenized DCW1*FLAG pool. We chose ApaLI, which cuts in the origin of replication. 2) Digest 1g of DNA from the DCW1*FLAG mutagenized entry pool in a 20l reaction. Include a negative controluse 100ng of DNA in a 20l reaction. 3) Digest 37C for 1 hour. 4) Run the entire negative control reaction, and 2l of the ApaLI digestion, on a gel to verify the backbone is fully digested. If digestion was successful, proceed.
Clean the linearized DNA 5) Add 82l ddH2O to the remaining ApaLI-digested DNA, to bring it to a final volume of 100l. 6) Add 100l phenol:chloroform:IAA. Vortex to mix. 7) Spin 5 minutes, 4C, 13500 rpm in microfuge. Remove and discard organic (bottom) layer. 8) Add 100 l chloroform. Vortex to mix. 9) Spin 5 minutes, 4C, 13500 rpm in microfuge. Transfer aqueous (top) later to a new 1.5ml microfuge tube. 10) Add 10 l 3M NaOAc. Add 220l ice-cold 100% EtOH. Chill at -20C for 15 minutes. 11) Spin 15 minutes, 4C, 13500 rpm in microfuge. Discard supernatant. 12) Wash DNA pellet with 500l ice-cold 70% EtOH. 13) Spin 5 minutes, 4C, 13500 rpm in microfuge. Discard supernatant. Allow pellet to air dry. 14) Resuspend DNA in 20l 10mM Tris. DNA will be 45ng/l.
Gateway LR Reaction -Move ORF to destination vector 1 reaction volume uses 150ng destination vector and 150ng (mutagenized, linearized) entry vector
15) Make a 2.5x reaction mixture DNA, which will be split into +LR and -LR reactions. Combine: 371.25ng (8.25l) mutagenized, linearized entry vector 371.25ng pRZ159 (DCW1 destination vector) Bring to 20l total volume with TE 16) For the "+LR" experimental reaction, combine 16l of the DNA mixture from step 15 and 4l Invitrogen LR Clonase II in a PCR tube. For the "-LR" control reaction, combine 4l DNA mixture from step 15 and 1l TE in a PCR tube. Incubate both reactions overnight at 25C on the PCR block. 17) Stop the LR reaction by adding proteinase K to the reactions: Add 2l proteinase K to the "+LR" experimental reaction; Add 0.5l proteinase K to the "-LR" negative control. 18) Incubate at 37C for 10 minutes on the PCR block. 19) Clean reactions: Transfer reactions to 1.5ml microfuge tubes. Perform phenol/chloroform extraction and EtOH precipitation as described before (steps 5-13 under "Clean linearized DNA") 20) Resuspend "+LR" experimental DNA in 6l TE (final [DNA] = 50ng/ul). 21) Resuspend "-LR" negative control DNA in 4l TE (final [DNA] = 18.75ng/ul).
Transform Gateway LR reactions
Transform cleaned LR reaction DNA into Invitrogen MegaX DH10B T1R electrocompetent E. coli cells. One set of steps is described for the "+ enzyme" reactions, another for "-enzyme" reactions. They can be performed in parallel, but are separated here for clarity. 30) The following morning, count the colonies growing on each plate. Calculate the number of independent transformants in the "+ enzyme" pools. 31) Make a glycerol frozen stock of the "+ enzyme" overnight culture. Store at -80C. 32) Pellet the remainder of the "+ enzyme" overnight culture in a 250ml conical tube. Spin 15 minutes at 3000 rpm.
Pellet can be stored at -20C, or continue to step 33 directly. 33) Purify the DNA from the "+ enzyme" culture cells using a Qiagen HiSpeed Midiprep Kit. Elute in 1ml 10mM Tris. This is the expression pool, selected for Car R ("xpC"). 24) The following morning, pull plates and count colonies. Calculate the number of independent transformants in your "+ ligase" pools. 25) Make a glycerol frozen stock of the "+ ligase" overnight culture. Store at -80C. 26) Pellet the remainder of the "+ ligase" overnight culture in a 250ml conical tube. Spin 15 minutes at 3000 rpm.
Pellet can be stored at -20C, or continue to step 37 directly. 27) Purify the DNA from the "+ ligase" culture cells using a Qiagen HiSpeed Midiprep Kit. Elute in 1ml 10mM Tris. This is the expression pool after removal of Tn7L ("xpT-L"). 53) The following morning, pull plates and count colonies. Calculate the number of independent transformants in your "+ ligase" pools. 54) Make a glycerol frozen stock of the "+ ligase" overnight culture. Store at -80C. 55) Pellet the remainder of the "+ ligase" overnight culture in a 250ml conical tube. Spin 15 minutes at 3000 rpm.
Remove Tn7R end with
Pellet can be stored at -20C, or continue to step 37 directly. 56) Purify the DNA from the "+ ligase" culture cells using a Qiagen HiSpeed Midiprep Kit. Elute in 1ml 10mM Tris. This is the expression pool after removal of both Tn7L and Tn7R("xpT-L-R").
Diagnostic digests
We highly recommend performing diagnostic restriction digests on plasmid pools from each phase of this protocol. This helps to characterize the proportion of each pool that is mutagenized, identify any lingering donor plasmid that persists in the expression pools, and helps determine the complexity of the pool (ie, is the Tn inserted at many locations throughout the target ORF?).
We suggest performing many restriction digests in parallel. Use an enzyme that cuts only in the donor backbone, one that cuts only in the expression backbone, one that cuts in the Tn7L, and one that cuts in Tn7R. Perform "no enzyme" controls, as well. Include one double digestion which cuts in the epitope tag and one in the backbone -this will determine the complexity of the mutagenized pool. Perform restriction digest on the following DNA samples:
1) Unmutagenized target donor vector 2) wt expression vector 3) mutagenized donor pool 4) xpC pool 5) xpT pool 6) xpT-L pool 7) xpT-L-R pool
File S2
Calculating fold coverage of Tn-mutagenized pools.
For entry pools: Fold coverage was calculated by dividing the number of Tmp R Kan R transformants by the length of plasmid DNA "available" for mutagenesis. The target plasmid, DCW1 entry vector, is 3608bp long. When considering the portions of the entry vector into which we could expect insertions, we excluded the origin (683 bp) and Kan R gene (807bp), because plasmids with insertions in these regions would not be expected to propagate. Thus, 4236bp (2118 bp x 2 strands of DNA) of sequence in DCW1 entry vector was available for mutagenesis. We observed 2.01 x 10 5 Tmp R Kan R colonies / 4236bp = 47-fold coverage.
For expression pools: There are 1373 bp between Gateway recombination sites in a wild type DCW1 expression vector. In our mutagenized expression pools, all Tn7 insertions will be present in this area, since that is the only region mobilized from the mutagenized DCW1 entry pool by Gateway recombination. Because the Tn7 can insert in either direction, we consider the "available" DNA for mutagenesis in these constructs to be 2746 bp long. Fold coverage is calculated using the number of Tmp R Car R colonies in the expression pools, or Car R colonies in the final pool. See Supplementary Note 3 for a discussion of how the number of Tmp R Car R colonies was calculated in the xpC pool. We observed 91x fold coverage in the initial expression pool (xpC), and recovered sufficiently numbers of transformants in subsequent steps to maintain this coverage. As the initial mutagenesis of the DCW1 entry vector had 47x coverage, these expression pools are sufficiently large to maintain the complexity present in the initial mutagenized entry pool.
File S3
Revising xpC pool sizes
To properly assess the size of the xpC pool, we found it was necessary to plate on selective media both pre-and post-Car selection. We suspect the MegaX E. coli cells are transformed with multiple plasmids and do not segregate them properly; thus the need to distinguish between cells that carry Tmp R and Car R on a single plasmid (as desired), and those that carry it on separate plasmids. Because of the possibility the strain carries multiple plasmids, co-selection with Tmp and Car may overestimate the true number of mutagenized expression plasmids in the pool (as counted from Iso+Tmp+Car plates). Theoretically, by performing the Car and Tmp selection sequentially, we minimize the selective pressure for MegaX cells to maintain multiple plasmids.
First, to assess the transformation efficiency, recovered cells were plated (prior to Car selection overnight) and found to contain 5x10 6 Car R colonies. This represents the number of independent expression vectors (mutagenized or not) in the xpC pool. Second, to determine how many of these Car R colonies are also Tmp R , we took a portion of the cells from the xpC pool (post-Car selection) onto LB+Car plates, and then replica plated to various selective media to determine the precise drug-resistance of each colony (Table S5 ).
In detail: cells from the xpC frozen stock were resuspended in PBS, diluted, and plated to get roughly 200 colonies per LB+Car plate; 4 LB+Car plates were used. These plates were grown overnight at 37C. Each LB+Car plate was then replica plated (in order) to LB+Kan, Iso+Tmp+Kan, Iso+Tmp, Iso+Tmp+Car, and LB+Car plates, and grown at 37C
overnight. The total number of colonies were counted on each plate. Additionally the Iso+Tmp+Car and Iso+Tmp+Kan were compared to identify any colonies resistant to Tmp, Car, and Kan. This would suggest a single cell contains two plasmid populations, indicating sub-optimal plasmid segregation in MegaX cells.
Calculations for drug resistance of colonies were performed as follows:
Tmp R Kan R Car R colonies = # colonies on Iso+Tmp+Kan plate (is Car R , based on growth on source plate). 
